Previous Pause Next
Home >> News Center >> Features >> The Burrill Features >>
Will Obama's Budget Hinder Innovation? PDF Print E-mail
User Rating :  / 0
Sunday, 19 February 2012 23:35

President Obama proposed budget for fiscal 2013 created concerns among researchers, the pharmaceutical industry, and patient advocates. Under it, NIH funding would remain flat, industry would shoulder a greater share of FDA’s expenses, and pharmaceutical companies would kick in an additional $156 billion in Medicare Part D rebates over the next 10 years. We spoke to Margaret Anderson, executive director of FasterCures, about the President's proposed budget, what it means for research and development, and what can be done to ensure pressure to cut spending doesn’t hinder innovation.

The Burrill Report (February 20, 2012): Will Obama's Budget Hinder Innovation? (.MP3,15.66 Mb)


Add comment  |   Add to my library  |  Forward this article

login to leave comment